Home » Topics » Regulatory

Regulatory
RSS

European Commission approves Zinforo

Aug. 29, 2012

NeutroPhase cleared for use in new indications

Aug. 28, 2012

FDA approves new combination pill for HIV

Aug. 28, 2012

Growject approved for fourth indication in Japan

Aug. 24, 2012

FDA approves sNDA for Tradjenta

Aug. 20, 2012

Marqibo receives accelerated approval

Aug. 13, 2012

Japanese authorities grant new approval to ultrasound contrast agent

Aug. 10, 2012

Humira approved for additional indication in Japan

Aug. 10, 2012

New vaccine approved in Japan for prevention of pertussis, diphtheria, tetanus and poliomyelitis

Aug. 7, 2012

Zaltrap approved in U.S. for cancer indication

Aug. 6, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...